Literature DB >> 21997311

Statin therapy reduces growth of abdominal aortic aneurysms.

Wassef Karrowni1, Saadeddine Dughman, Georges P Hajj, Francis J Miller.   

Abstract

BACKGROUND: The aim of this study was to evaluate the influence of statins on the growth of small abdominal aortic aneurysms (AAAs).
METHODS: We retrospectively examined AAA diameter in 211 patients who had undergone serial imaging surveillance.
RESULTS: Patients treated with and without statins were similar regarding age, initial aneurysm size, diagnosis of diabetes and hypertension, and smoking history. Patients receiving statins had a decreased aneurysm growth rate compared with those patients not receiving statins (0.9 mm/y [interquartile range, -1.0 to +1.0] vs 3.2 mm/y [interquartile range, 2.0-4.9], P < 0.0001). This difference in the rate of growth was maintained after adjusting for potential confounding factors.
CONCLUSIONS: To date, this is the one of the largest retrospective studies demonstrating an association between statin use and decreased growth rate of AAA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997311      PMCID: PMC3219796          DOI: 10.2130/JIM.0b013e31823548e8

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  56 in total

1.  Risk factors for abdominal aortic aneurysm: results of a case-control study.

Authors:  J F Blanchard; H K Armenian; P P Friesen
Journal:  Am J Epidemiol       Date:  2000-03-15       Impact factor: 4.897

2.  Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms.

Authors:  J T Powell; A R Brady; L C Brown; F G R Fowkes; R M Greenhalgh; C V Ruckley; S G Thompson
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

3.  Immediate repair compared with surveillance of small abdominal aortic aneurysms.

Authors:  Frank A Lederle; Samuel E Wilson; Gary R Johnson; Donovan B Reinke; Fred N Littooy; Charles W Acher; David J Ballard; Louis M Messina; Ian L Gordon; Edmund P Chute; William C Krupski; Steven J Busuttil; Gary W Barone; Steven Sparks; Linda M Graham; Joseph H Rapp; Michel S Makaroun; Gregory L Moneta; Robert A Cambria; Raymond G Makhoul; Darwin Eton; Howard J Ansel; Julie A Freischlag; Dennis Bandyk
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

4.  Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms.

Authors:  S Goodall; M Crowther; D M Hemingway; P R Bell; M M Thompson
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

5.  Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.

Authors:  E Petersen; A Gineitis; F Wågberg; K A Angquist
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

6.  Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling.

Authors:  Francis J Miller; William J Sharp; Xiang Fang; Larry W Oberley; Terry D Oberley; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

7.  Screening for abdominal aortic aneurysm: lessons from a population-based study.

Authors:  K Jamrozik; P E Norman; C A Spencer; R W Parsons; R Tuohy; M M Lawrence-Brown; J A Dickinson
Journal:  Med J Aust       Date:  2000-10-02       Impact factor: 7.738

8.  Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.

Authors:  S Liao; M Miralles; B J Kelley; J A Curci; M Borhani; R W Thompson
Journal:  J Vasc Surg       Date:  2001-05       Impact factor: 4.268

Review 9.  Management of abdominal aortic aneurysms.

Authors:  J W Hallett
Journal:  Mayo Clin Proc       Date:  2000-04       Impact factor: 7.616

10.  A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.

Authors:  Hirotaka Nagashima; Yoshikazu Aoka; Yasunari Sakomura; Akiko Sakuta; Shigeyuki Aomi; Naoko Ishizuka; Nobuhisa Hagiwara; Masatoshi Kawana; Hiroshi Kasanuki
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

View more
  14 in total

Review 1.  Effect of Statin Therapy on Survival After Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.

Authors:  Qun Huang; Han Yang; Qiuning Lin; Ming Hu; Yuanbiao Meng; Xiao Qin
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 2.  MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.

Authors:  Yongqi Li; Weicheng Wang; Lei Li; Raouf A Khalil
Journal:  Life Sci       Date:  2020-04-10       Impact factor: 5.037

Review 3.  Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Authors:  Yanwen Qin; Xu Cao; Yaoguo Yang; Guo-Ping Shi
Journal:  Future Cardiol       Date:  2013-01

4.  Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.

Authors:  Koichi Yoshimura; Ayako Nagasawa; Junichi Kudo; Masahiko Onoda; Noriyasu Morikage; Akira Furutani; Hiroki Aoki; Kimikazu Hamano
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

5.  Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms.

Authors:  O M B McBride; N V Joshi; J M J Robson; T J MacGillivray; C D Gray; A M Fletcher; M R Dweck; E J R van Beek; J H F Rudd; D E Newby; S I Semple
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-02-23       Impact factor: 7.069

6.  Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.

Authors:  Yuanyuan Li; Gangsheng Lu; Dating Sun; Houjuan Zuo; Dao Wen Wang; Jiangtao Yan
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

7.  Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms.

Authors:  Hui Ma; Wen-Jing Liang; Mei-Rong Shan; Xue-Qing Wang; Sheng-Nan Zhou; Yuan Chen; Tao Guo; Peng Li; Hai-Ya Yu; Chao Liu; Ya-Ling Yin; Yu-Lin Wang; Bo Dong; Xin-Yan Pang; Shuang-Xi Wang
Journal:  Oncotarget       Date:  2017-02-28

Review 8.  Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

Authors:  Koichi Yoshimura; Noriyasu Morikage; Shizuka Nishino-Fujimoto; Akira Furutani; Bungo Shirasawa; Kimikazu Hamano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

9.  Recent advances in pharmacotherapy development for abdominal aortic aneurysm.

Authors:  Koichi Yoshimura; Hiroki Aoki
Journal:  Int J Vasc Med       Date:  2012-08-21

10.  A Novel Hybrid Drug Delivery System for Treatment of Aortic Aneurysms.

Authors:  Koichi Yoshimura; Hiroki Aoki; Chie Teruyama; Masumi Iijima; Hiromori Tsutsumi; Shun'ichi Kuroda; Kimikazu Hamano
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.